J Korean Epilepsy Soc.  2011 Dec;15(1):1-9.

Pharmacokinetics and Therapeutic Drug Monitoring of Newer Antiepileptic Drugs

Affiliations
  • 1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. daewon@skku.edu

Abstract

Recently a newer generation of antiepileptic drugs has been developed and rational polytherapy has become popular in everyday clinical practice for epilepsy management. All of newer antiepileptic drugs (AED) have undergone extensive clinical studies, but the information on the relationship between concentrations and effects is scarce. The concentration can depend on the individual variation, but explain the efficacy and toxicity in individual patient management. We assess the potential value of measuring the level of newer AED, which is one of therapeutic drug monitoring (TDM). The value of TDM is discussed based on pharmacokinetic characteristics and drug interactions. Although routine TDM in general cannot be recommended, TDM of the newer AED may be of value in selected cases.

Keyword

Epilepsy; Antiepileptic drug; Therapeutic drug monitoring; Pharmacokinetics

MeSH Terms

Anticonvulsants
Drug Interactions
Drug Monitoring
Epilepsy
Humans
Anticonvulsants
Full Text Links
  • JKES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr